Antigen-Processing Machinery in Clear-Cell Renal Cell Carcinoma: RNA-Adjusted Protein Abundance Across Histologic Grade
Background/Objectives: Bulk antigen-processing machinery (APM) measurements combine RNA and protein abundance across malignant, immune and stromal cells. We examined whether high-grade clear-cell renal cell carcinoma (ccRCC) had lower APM protein abundance after accounting for corresponding RNA and whether the conditional pattern was specific to antigen processing. Methods: A coverage-defined seven-gene panel was analyzed in CPTAC discovery (n = 94), a later-added, nonoverlapping CPTAC confirmation set (n = 77) and Tongji (n = 100). Discovery eligibility was corrected using exact source disease labels, and affected scores and models were rebuilt. Cohort-specific models used HC3 robust standard errors. Specificity was assessed against 1000 matched background panels. Results: Adjusted high-grade minus low-grade protein differences were +0.169 SD (95% CI −0.143 to 0.480), +0.289 SD (−0.043 to 0.621) and +0.212 SD (−0.150 to 0.574); all intervals included zero. RNA–protein correlations were 0.784, 0.671 and 0.487. RNA-by-grade interactions were nonsignificant, and the panel coefficients were not exceptional relative to matched backgrounds. Post hoc tests were inconsistent with decreases of at least 0.200 SD under the fitted models, without establishing equivalence within ±0.300 SD. Conclusions: The measured bulk APM panel did not support the hypothesized high-grade protein deficit after RNA adjustment. These results refine the interpretation of tissue-level immune measurements and prioritize cell-resolved and functional follow-up. They do not establish intact antigen presentation, a post-transcriptional mechanism, immune escape or clinical utility.
Authors
- Lemmuel Lara Tayo (ORCID: https://orcid.org/0000-0002-0869-2131)
- Ayena Kristin P. Pascual (ORCID: https://orcid.org/0009-0003-2638-8859)
- Xyryll C. Kadatuan
Institutions
- Mapúa University (PH)
Publication Details
- Journal
- Onco
- Published
- 2026-11-20
- DOI
- https://doi.org/10.3390/onco6040057
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00